. . .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .speaking after a four-day inquest, the family of brigid cavanagh, who died on july 20, 2016, said the western health trust should be ashamed after the 83-year-old had died in "terror".